Long-term results of the children's cancer group studies for childhood acute lymphoblastic leukemia 1983–2002: A Children's Oncology Group Report-Reference-Cited by-同舟云学术

Long-term results of the children's cancer group studies for childhood acute lymphoblastic leukemia 1983–2002: A Children's Oncology Group Report

Published:2009-12-17 Issue:2 Volume:24 Page:285-297
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Gaynon P S, ,Angiolillo A L,Carroll W L,Nachman J B,Trigg M E,Sather H N,Hunger S P,Devidas M

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2009262.pdf

Reference71 articles.

1. Pinkel D, Simone J, Hustu HO, Aur RJ . Nine years' experience with ‘total therapy’ of childhood acute lymphocytic leukemia. Pediatrics 1972; 50: 246–251.

2. Henze G, Langermann HJ, Bramswig J, Breu H, Gadner H, Schellong G et al. The BFM 76/79 acute lymphoblastic leukemia therapy study (author's transl). Klin Padiatr 1981; 193: 145–154.

3. Bleyer WA, Coccia PF, Sather HN, Level C, Lukens J, Niebrugge DJ et al. Reduction in central nervous system leukemia with a pharmacokinetically derived IT methotrexate dosage regimen. J Clin Oncol 1983; 1: 317–325.

4. Miller DR, Leikin S, Albo V, Sather H, Karon M, Hammond D . Prognostic factors and therapy in acute lymphoblastic leukemia of childhood: CCG-141. A report from the Children's Cancer Study Group. Cancer 1983; 51: 1041–1049.

5. Bleyer WA, Sather HN, Nickerson HJ, Coccia PF, Finklestein JZ, Miller DR et al. Monthly pulses of vincristine and prednisone prevent bone marrow and testicular relapse in low-risk childhood acute lymphoblastic leukemia: a report of the CCG-161 study by the Childrens Cancer Study Group. J Clin Oncol 1991; 9: 1012–1021.

Cited by 231 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Outcome of Modified St. Jude Total XV Protocol in Turkish Children with Newly Diagnosed Acute Lymphoblastic Leukemia: A Single-Center Retrospective Analysis;Turkish Journal of Hematology;2024-08-05

2. Prediction of Response to FDA-Approved Targeted Therapy and Immunotherapy in Acute Lymphoblastic Leukemia (ALL);Current Treatment Options in Oncology;2024-08-05

3. Screening and interventional strategies for the late effects and toxicities of hematological malignancy treatments in pediatric survivors;Expert Review of Hematology;2024-06-25

4. Haploidentical HSCT in the Treatment of Pediatric Hematological Disorders;International Journal of Molecular Sciences;2024-06-09

5. Genetic Factors and Long-term Treatment-related Neurocognitive Deficits, Anxiety, and Depression in Childhood Leukemia Survivors: An Exome-Wide Association Study;Cancer Epidemiology, Biomarkers & Prevention;2024-01-03